What is MAZE's EPS (basic)?

MAZE (MAZE) reported EPS (basic) of -$0.45 in Q1 2026.

How has MAZE's EPS (basic) changed year-over-year?

MAZE's EPS (basic) increased by 60.9% year-over-year, from -$1.15 to -$0.45.

What does EPS (basic) mean?

Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.

MAZE MAZE EPS (Basic)

EPS (Basic) at other companies

Vertex PharmaceuticalsVRTX

$4.06+61.1%

Septerna, Inc.SEPN

-$0.19+61.2%

Stoke Therapeutics, Inc.STOK

-$0.79-141%

Olema Pharmaceuticals, Inc.OLMA

-$0.52-44.4%

ZymeworksZYME

-$0.59-96.7%

Nurix Therapeutics, Inc.NRIX

-$0.79-17.9%

Other financials

Income statement

See full

Revenue$20.0M—

Operating income-$26.6M+25.0%

Net income-$24.2M+26.2%

EPS (diluted)-$0.45+60.9%

Balance sheet

See full

Cash & equivalents$198.8M-32.5%

Total debt$61.2M+137%

Total equity$341.7M+17.0%

Total assets$419.7M+26.1%

Cash flow

See full

Operating cash flow-$39.1M-32.5%

CapEx$93.0K-68.9%

Free cash flow-$39.2M-31.5%

Valuation

See full

Market cap$1.48B+201%

Enterprise value$1.34B—

P/S7.9×—

Profitability

See full

Operating margin-71.5%—

Net margin-65.4%—

FCF margin-65.1%—

Returns & leverage

See full

Return on equity-38.7%—

Debt / equity0.2×+0.1×

Current ratio17.9×+1.8×

Where this comes from

Reported directly by MAZE in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The official record: MAZE’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about MAZE's eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MAZE's EPS (basic)?: MAZE (MAZE) reported EPS (basic) of -$0.45 in Q1 2026.
How has MAZE's EPS (basic) changed year-over-year?: MAZE's EPS (basic) increased by 60.9% year-over-year, from -$1.15 to -$0.45.
What does EPS (basic) mean?: Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.